Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nivaquine 68mg/5ml syrup
0504010G0BBABAF
|
Nivaquine | Chloroquine sulfate | Infections | No data available |
|
Nivemycin 500mg tablets
0501040N0BCAAAD
|
Nivemycin (Systemic) | Neomycin sulfate | Infections | No data available |
|
Nivestim 12million units/0.2ml inj pre-filled syringes
0901060I0BEAAAP
|
Nivestim | Filgrastim | Nutrition and Blood | No data available |
|
Nivestim 48million units/0.5ml inj pre-filled syringes
0901060I0BEACAM
|
Nivestim | Filgrastim | Nutrition and Blood | No data available |
|
Nivolumab 100mg/10ml solution for infusion vials
0802040ATAAABAB
|
Nivolumab (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nivolumab 240mg/24ml solution for infusion vials
0802040ATAAACAC
|
Nivolumab (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nivolumab 40mg/4ml solution for infusion vials
0802040ATAAAAAA
|
Nivolumab (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nivolumab BMS 100mg/10ml concentrate for inf vials
0802040ATBCAAAB
|
Nivolumab BMS (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nivolumab BMS 40mg/4ml concentrate for inf vials
0802040ATBCABAA
|
Nivolumab BMS (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Nizatidine 100mg/4ml solution for infusion ampoules
0103010N0AAACAC
|
Nizatidine | Nizatidine | Gastro-Intestinal System | No data available |
|
Nizatidine 150mg/5ml oral liquid
0103010N0AAADAD
|
Nizatidine | Nizatidine | Gastro-Intestinal System | No data available |
|
Nizoral 200mg tablets
0502020A0BBAAAC
|
Nizoral (Systemic) | Ketoconazole | Infections | No data available |
|
Nizoral Scalp Soothing Dry & Eczema Prone shampoo
190205500BDAAAL
|
Nizoral | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Nizorelle 1% shampoo
1309000I0BCAAAC
|
Nizorelle | Ketoconazole | Skin | No data available |
|
NKH Anamix Infant powder
0913571A0BBAAAA
|
NKH Anamix Infant pdr disc/non ACBS Prot SfI met cond (inf) | Pdr disc/non ACBS Protein SfI metabolic cond (inf) (091357) | Nutrition and Blood | No data available |
|
Nobligan retard 100mg tablets
040702040BMAAAC
|
Nobligan retard | Tramadol hydrochloride | Central Nervous System | No data available |
|
Noctura 400 Sleep Mask
21300000991
|
Noctura 400 Sleep Mask | Eye Products | Appliances | No data available |
|
Nocutil 10micrograms/dose nasal spray
0605020E0BGAAAC
|
Nocutil | Desmopressin acetate | Endocrine System | No data available |
|
Nolvadex 10mg tablets
0803041S0BCAAAA
|
Nolvadex | Tamoxifen citrate | Malignant Disease and Immunosuppression | No data available |
|
Non-adhesive colostomy outfit
23404304005
|
Non-adhesive colostomy outfit | Colostomy Sets | Stoma Appliances | No data available |
|
Non-allergenic sheath
22902409168
|
Non-allergenic sheath | Urinal Systems | Incontinence Appliances | No data available |
|
Non-drainable night drainage bag
22603606001
|
Non-drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | No data available |
|
Non-drainable night drainage bag 2litre, 90cm inlet
22605086000
|
Non-drainable night drainage bag 2litre, 90cm inlet | Night Drainage Bags | Incontinence Appliances | No data available |
|
Non-slip elastic ostomy belt with button and buckle 102cm
23305853083
|
Non-slip elastic ostomy belt with button and buckle 102cm | Belts | Stoma Appliances | No data available |
|
Non-slip elastic ostomy belt with button and buckle 112cm
23302403039
|
Non-slip elastic ostomy belt with button and buckle 112cm | Belts | Stoma Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.